103 related articles for article (PubMed ID: 12430181)
1. GSTT1 null genotype increases risk of premenopausal breast cancer.
Matheson MC; Stevenson T; Akbarzadeh S; Propert DN
Cancer Lett; 2002 Jul; 181(1):73-9. PubMed ID: 12430181
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
[TBL] [Abstract][Full Text] [Related]
3. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.
Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J
Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248
[TBL] [Abstract][Full Text] [Related]
6. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility.
García-Closas M; Kelsey KT; Hankinson SE; Spiegelman D; Springer K; Willett WC; Speizer FE; Hunter DJ
J Natl Cancer Inst; 1999 Nov; 91(22):1960-4. PubMed ID: 10564681
[TBL] [Abstract][Full Text] [Related]
8. GSTM1 null genotype, red meat consumption and breast cancer risk (The Netherlands).
van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Ocké M; Bueno de Mesquita HB
Cancer Causes Control; 2004 Apr; 15(3):295-303. PubMed ID: 15090724
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
[TBL] [Abstract][Full Text] [Related]
10. Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population.
Nesa A; Mostafijur Rahman M; Tahminur Rahman M; Kabir Y
Gene; 2023 Jun; 868():147368. PubMed ID: 36963735
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effect between the Mediterranean diet and GSTP1 or NAT2 SNPs decreases breast cancer risk in Greek-Cypriot women.
Kakkoura MG; Loizidou MA; Demetriou CA; Loucaides G; Daniel M; Kyriacou K; Hadjisavvas A
Eur J Nutr; 2017 Mar; 56(2):545-555. PubMed ID: 26572891
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant enzymes, presbycusis, and ethnic variability.
Bared A; Ouyang X; Angeli S; Du LL; Hoang K; Yan D; Liu XZ
Otolaryngol Head Neck Surg; 2010 Aug; 143(2):263-8. PubMed ID: 20647132
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
15. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
[TBL] [Abstract][Full Text] [Related]
16. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
17. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
Gates MA; Tworoger SS; Terry KL; Titus-Ernstoff L; Rosner B; De Vivo I; Cramer DW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2436-44. PubMed ID: 18768514
[TBL] [Abstract][Full Text] [Related]
18. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
19. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk.
Park SK; Yoo KY; Lee SJ; Kim SU; Ahn SH; Noh DY; Choe KJ; Strickland PT; Hirvonen A; Kang D
Pharmacogenetics; 2000 Jun; 10(4):301-9. PubMed ID: 10862521
[TBL] [Abstract][Full Text] [Related]
20. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
